Generation of high rapamycin producing strain via rational metabolic pathway‐based mutagenesis and further titer improvement with fed‐batch bioprocess optimization
Abstract
Rapamycin is a triene macrolide antibiotic produced by Streptomyces hygroscopicus. Besides its wide application as an effective immunosuppressive agent, other important bioactivities have made rapamycin a potential drug lead for novel pharmaceutical development. However, the low titer of rapamycin in the original producer strain limits further industrialization efforts and restricts its use for other applications. Predicated on knowledge of the metabolic pathways related to rapamycin biosynthesis in S. hygroscopicus, we have rationally designed approaches to generate a rapamycin high producer strain of S. hygroscopicus HD‐04‐S. These have included alleviation of glucose repression, improved tolerance towards lysine and shikimic acid, and auxotrophy of tryptophan and phenylalanine through the application of stepwise UV mutagenesis. The resultant strain produced rapamycin at 450 mg/L in the shake flask scale. These fermentations were further scaled up in 120 and 20,000 L fermentors, respectively, at the pilot plant. Selected fermentation factors including agitation speed, pH, and on‐line supplementation were systematically evaluated. A fed‐batch strategy was established to maximize rapamycin production. With these efforts, an optimized fermentation process in the larger scale fermentor was developed. The final titer of rapamycin was 812 mg/L in the 120 L fermentor and 783 mg/L in the 20,000 L fermentor. This work highlights a high rapamycin producing strain derived by mutagenesis and subsequent screening, fermentation optimization of which has now made it feasible to produce rapamycin on an industrial scale by fermentation. The strategies developed here should also be applicable to titer improvement of other important microbial natural products on an industrial scale. Biotechnol. Bioeng. 2010;107: 506–515. © 2010 Wiley Periodicals, Inc.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Low titer of rapamycin produced by S. hygroscopicus limits further development and industrialization of this natural product.
“The low titer of this drug produced by the organism has now become a rate-limiting factor in further development and industrialization of this natural product (Zhu et al. 2010).”
From Kinetics of rapamycin production by Streptomyces hygroscopicus MTCC 4003 (2014) · cites this paper as Zhu et al. 2010
The dissolved oxygen level was maintained at 10% of saturation level all the time.
“Finally, the DO level was maintained at 10 % of saturation level all the time (Zhu et al. 2010).”
From Kinetics of rapamycin production by Streptomyces hygroscopicus MTCC 4003 (2014) · cites this paper as Zhu et al. 2010
The obtained data clearly show that exponential phase of growth is very important for rapamycin production.
“However, the obtained data clearly show that exponential phase of growth is very important for rapamycin production (Zhu et al. 2010; Sanchez and Brana 1996).”
From Kinetics of rapamycin production by Streptomyces hygroscopicus MTCC 4003 (2014) · cites this paper as Zhu et al. 2010
Cites
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · see citing works
The biosynthetic gene cluster for the polyketide immunosuppressant rapamycin.
Schwecke, T., Aparicio, J. F., Molnár, I., König, A., Khaw, L. E., Haydock, S. F., Oliynyk, M., Caffrey, P., Cortés, J., & Lester, J. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7839 · Cited by 446 · see citing works
Mechanism of action of the immunosuppressant rapamycin
Dumont, F. J., & Su, Q. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02233-3 · Cited by 356 · see citing works
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
Tain, L. S., Mortiboys, H., Tao, R. N., Ziviani, E., Bandmann, O., & Whitworth, A. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2372 · Cited by 323 · see citing works
Biosynthesis of Erythromycin and Rapamycin
Staunton, J., & Wilkinson, B. M. (1997) · Chemical Reviews · doi:10.1021/cr9600316 · Cited by 261 · see citing works
RAPAMYCIN: CLINICAL RESULTS AND FUTURE OPPORTUNITIES1
Kahan, B. D., & Camardo, J. S. (2001) · Transplantation · doi:10.1097/00007890-200110150-00001 · Cited by 225 · see citing works
Perera, S. A., Li, D., Shimamura, T., Raso, M. G., Ji, H., Chen, L., Borgman, C. L., Zaghlul, S., Brandstetter, K. A., Kubo, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808930106 · Cited by 185 · see citing works
Kobayashi, S., Kishimoto, T., Kamata, S., Otsuka, M., Miyazaki, M., & Ishikura, H. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00439.x · Cited by 157 · see citing works
Gatto, G. J. J., Boyne, M. T., Kelleher, N. L., & Walsh, C. T. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0587603 · Cited by 151 · see citing works
Molnár, I., Aparicio, J. F., Haydock, S. F., Khaw, L. E., Schwecke, T., König, A., Staunton, J., & Leadlay, P. F. (1996) · Gene · doi:10.1016/0378-1119(95)00799-7 · Cited by 144 · see citing works
Khaw, L. E., Böhm, G. A., Metcalfe, S. M., Staunton, J., & Leadlay, P. F. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.4.809-814.1998 · Cited by 91 · see citing works
Zou, C., Smith, K. D., Zhu, Q.-S., Liu, J., McCutcheon, I. E., Slopis, J. M., Meric‐Bernstam, F., Peng, Z., Bornmann, W. G., Mills, G. B., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1008 · Cited by 86 · see citing works
Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs
Graziani, E. I. (2009) · Natural Product Reports · doi:10.1039/b804602f · Cited by 71 · see citing works
Incorporation of Acetate, Propionate, and Methionine into Rapamycin by Streptomyces hygroscopicus
Paiva, N. L., Demain, A. L., & Roberts, M. F. (1991) · Journal of Natural Products · doi:10.1021/np50073a015 · Cited by 69 · see citing works
Effect of nitrogen source on biosynthesis of rapamycin by Streptomyces hygroscopicus
Lee, M. S., Kojima, I., & Demain, A. L. (1997) · Journal of Industrial Microbiology & Biotechnology · doi:10.1038/sj.jim.2900434 · Cited by 61 · see citing works
Carbon source nutrition of rapamycin biosynthesis inStreptomyces hygroscopicus
Kojima, I., Cheng, Y. R., Mohan, V. P., & Demain, A. L. (1995) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/bf01573954 · Cited by 57 · see citing works
Xu, Z., Shen, W., Chen, X.-Y., Lin, J., & Cen, P. (2005) · Biotechnology Letters · doi:10.1007/s10529-005-8463-y · Cited by 54 · see citing works
Self-citationNicoletti, F., Lamenta, C., Donati, S., Spada, M., Ranazzi, A., Cacopardo, B. S., Mangano, K., Belardelli, F., Perno, C. F., & Aquaro, S. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03780.x · Cited by 54 · see citing works
Ruan, X., Stassi, D. L., Lax, S. A., & Katz, L. (1997) · Gene · doi:10.1016/s0378-1119(97)00450-2 · Cited by 52 · see citing works
New Rapamycin Derivatives by Precursor‐Directed Biosynthesis
Lowden, P. A. S., Böhm, G. A., Metcalfe, S. M., Staunton, J., & Leadlay, P. F. (2004) · ChemBioChem · doi:10.1002/cbic.200300758 · Cited by 51 · see citing works
Rapamycin biosynthesis: elucidation of gene product function
Gregory, M. A., Hong, H., Lill, R. E., Gaisser, S., Petković, H., Low, L., Sheehan, L. S., Carletti, I., Ready, S. J., Ward, M. J., et al. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b608813a · Cited by 48 · see citing works
Resistance to Rapamycin: A Novel Anticancer Drug
Huang, S., & Houghton, P. J. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013167315885 · Cited by 44 · see citing works
The cyclohexane moiety of rapamycin is derived from shikimic acid inStreptomyces hygroscopicus
Paiva, N. L., Roberts, M. F., & Demain, A. L. (1993) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/bf01569676 · Cited by 44 · see citing works
Generation of high-yield rapamycin-producing strains through protoplasts-related techniques
Chen, X., Wei, P., Fan, L., Yang, D. J., Zhu, X., Shen, W., Xu, Z., & Cen, P. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-1918-7 · Cited by 41 · see citing works
Self-citationThe immediate precursor of the nitrogen-containing ring of rapamycin is free pipecolic acid
Paiva, N. L., Demain, A. L., & Roberts, M. F. (1993) · Enzyme and Microbial Technology · doi:10.1016/0141-0229(93)90020-3 · Cited by 40 · see citing works
Efficacy of rapamycin in patient with juvenile rheumatoid arthritis
Foroncewicz, B., Mucha, K., Pączek, L., Chmura, A., & Rowinski, W. A. (2005) · Transplant International · doi:10.1111/j.1432-2277.2004.00070.x · Cited by 34 · see citing works
Goss, R. J. M., Lanceron, S., Wise, N. J., & Moss, S. J. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b614519c · Cited by 31 · see citing works
New process control strategy used in a rapamycin fermentation
Chen, Y., Krol, J., Sterkin, V. E., Fan, W., Yan, X., Huang, W., Cino, J., & Julien, C. (1999) · Process Biochemistry · doi:10.1016/s0032-9592(98)00108-3 · Cited by 26 · see citing works
Kim, S. H., Zukowski, K. L., & NOVAK, R. F. (2009) · PubMed · Cited by 19 · see citing works
DCO2 on-line measurement used in rapamycin fed-batch fermentation process
Chen, Y., Krol, J., Huang, W., Cino, J., Vyas, R., Mirro, R., & Vaillancourt, B. (2008) · Process Biochemistry · doi:10.1016/j.procbio.2007.12.013 · Cited by 16 · see citing works
Emerging strategies for the clinical application of rapamycin
Kahan, B. D. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00044-7 · Cited by 12 · see citing works
Shi, Y., & August, D. A. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.3.5871 · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Impact of novel microbial secondary metabolites on the pharma industry
Ramírez-Rendón, D., Passari, A. K., Ruiz‐Villafán, B., Rodrı́guez-Sanoja, R., Sánchez, S., & Demain, A. L. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-11821-5 · Cited by 90 · see citing works
Huang, D., Xia, M., Li, S., Wen, J., & Jia, X. (2013) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-013-1301-7 · Cited by 73 · see citing works
Jung, W. S., Yoo, Y. J., Park, J. W., Park, S. R., Han, A. R., Ban, Y. H., Kim, E. J., Kim, E., & Yoon, Y. J. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3348-6 · Cited by 68 · see citing works
Mo, S., Lee, S., Jin, Y., Oh, C., & Suh, J. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4413-5 · Cited by 52 · see citing works
Ng, I., Ye, C., Zhang, Z.-X., Lu, Y., & Jing, K. (2013) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-013-1007-2 · Cited by 45 · see citing works
Kim, Y. H., Park, B. S., Bhatia, S. K., Seo, H., Jeon, J.-M., Kim, H., Yi, D.-H., Lee, J.-H., Choi, K., Park, H., et al. (2014) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1403.03024 · Cited by 46 · see citing works
Xia, X. S., Lin, S., Xia, X., Cong, F., & Zhong, J. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5555-4 · Cited by 41 · see citing works
Ding, Q., Luo, Q., Zhou, J., Chen, X., & Liu, L. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9272-2 · Cited by 38 · see citing works
Self-citationYoungquist, J. T., Lennen, R. M., Ranatunga, D. R., Bothfeld, W., Marner, W. D., & Pfleger, B. F. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.24420 · Cited by 36 · see citing works
Application of Mini- and Micro-Bioreactors for Microbial Bioprocesses
Ladner, T., Grünberger, A., Probst, C., Kohlheyer, D., Büchs, J., & Delvigne, F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-444-63663-8.00015-x · Cited by 32 · see citing works
Zou, S., Zhong, W., Xia, C.-J., Gu, Y., Niu, K., Zheng, Y., & Shen, Y. (2015) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-015-1425-4 · Cited by 32 · see citing works
Zhu, X., Kong, J., Yang, H., Huang, R., Huang, Y. P., Yang, D. J., Shen, B., & Duan, Y. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8705-7 · Cited by 31 · see citing works
Self-citationOrdóñez-Robles, M., Santos‐Beneit, F., & Martin, J. F. (2018) · Antibiotics · doi:10.3390/antibiotics7020039 · Cited by 31 · see citing works
Zambry, N. S., Rusly, N. S., Awang, M. S., Noh, N. A. M., & Yahya, A. R. M. (2021) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-021-02543-5 · Cited by 29 · see citing works
Du, Z., Zhang, Y., Qian, Z., Xiao, H., & Zhong, J. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26396 · Cited by 28 · see citing works
Wang, B., Liu, J., Liu, H., Huang, D., & Wen, J. (2015) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-015-1611-z · Cited by 27 · see citing works
Kinetics of rapamycin production by Streptomyces hygroscopicus MTCC 4003
Dutta, S., Basak, B., Bhunia, B., Chakraborty, S., & Dey, A. (2014) · 3 Biotech · doi:10.1007/s13205-013-0189-2 · Cited by 26 · see citing works
Qi, H., Zhao, S., Wen, J., Chen, Y., & Jia, X. (2013) · Biochemical Engineering Journal · doi:10.1016/j.bej.2013.11.006 · Cited by 25 · see citing works
Production and partial characterization of biosurfactant produced by Streptomyces sp. R1
Zambry, N. S., Ayoib, A., Noh, N. A. M., & Yahya, A. R. M. (2017) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-017-1764-4 · Cited by 24 · see citing works
Advances in bio‐based production of dicarboxylic acids longer than C4
Yu, J., Qian, Z., & Zhong, J. (2018) · Engineering in Life Sciences · doi:10.1002/elsc.201800023 · Cited by 24 · see citing works
Zhao, S., Huang, D., Qi, H., Wen, J., & Jia, X. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-4852-7 · Cited by 21 · see citing works
Wang, P., Yin, Y., Wang, X., & Wen, J. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01561-y · Cited by 20 · see citing works
Netzker, T., Schroeckh, V., Gregory, M. A., Flak, M., Krespach, M. K. C., Leadlay, P. F., & Brakhage, A. A. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.00371-16 · Cited by 19 · see citing works
Tang, J., He, H., Li, Y., Liu, Z., Xia, Z., Cao, L., Zhu, Z., Shuai, L., Liu, Y., Wan, Q., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c03654 · Cited by 18 · see citing works
Sinha, R., Singh, S., & Srivastava, P. (2013) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-013-1051-y · Cited by 18 · see citing works
Du, Z., & Zhong, J. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26775 · Cited by 17 · see citing works
Wei, P., Si, Z., Lü, Y., Yu, Q., Huang, L., & Xu, Z. (2017) · Preparative Biochemistry & Biotechnology · doi:10.1080/10826068.2017.1315596 · Cited by 16 · see citing works
Self-citationPeriodic-peristole agitation for process enhancement of butanol fermentation
Xia, M., Wang, L., Yang, Z., & Chen, H. (2015) · Biotechnology for Biofuels · doi:10.1186/s13068-015-0409-6 · Cited by 15 · see citing works
Zou, X., & Li, J. (2013) · Annals of Microbiology · doi:10.1007/s13213-012-0597-2 · Cited by 13 · see citing works
Li, Y., Li, J., Ye, Z., & Lu, L. (2020) · Preparative Biochemistry & Biotechnology · doi:10.1080/10826068.2020.1805754 · Cited by 13 · see citing works
Qi, H., Zhao, S., Fu, H., Wen, J., & Jia, X. (2014) · Biochemical Engineering Journal · doi:10.1016/j.bej.2014.08.015 · Cited by 12 · see citing works
Zhang, B., Zhang, Y., Chen, Y., Chen, K., Jiang, S.-X., Huang, K., Liu, Z., & Zheng, Y. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00597 · Cited by 11 · see citing works
Yen, H., Hsiao, H.-P., & Chen, L. (2013) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2013.01.025 · Cited by 11 · see citing works
Dutta, S., Bhunia, B., Raju, A., Maity, N., & Dey, A. (2019) · Chemical Papers · doi:10.1007/s11696-019-00767-0 · Cited by 10 · see citing works
Qiu, L., Su, M., Wen, Z., Zhu, X., Duan, Y., & Huang, Y. P. (2019) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201900338 · Cited by 7 · see citing works
Self-citationRezkalla, M., & Simmons, J. L. (1995) · PubMed · Cited by 6 · see citing works
Geng, H., Liu, H., Liu, J., Wang, C., & Wen, J. (2017) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-017-2266-x · Cited by 6 · see citing works
Sinha, R., Anand, S., Singh, D., Tripathi, S., Shukla, P., Singh, S., & Srivastava, P. (2022) · Chemical Engineering and Processing - Process Intensification · doi:10.1016/j.cep.2022.108797 · Cited by 5 · see citing works
Jiao, W.-C., Zhao, X., Wang, Y., & Geng, X. (2013) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2013.07.012 · Cited by 4 · see citing works
RetractedZhang, D., Chen, J., Wang, Z., & Wang, C. (2022) · Microorganisms · doi:10.3390/microorganisms10112205 · Cited by 3 · see citing works
Yen, H., & Chiang, M.-H. (2015) · Bioresources and Bioprocessing · doi:10.1186/s40643-015-0071-7 · Cited by 2 · see citing works
Panahi, H. K. S., Mohammadipanah, F., Rahmati, F., Tarlani, A., & Hamedi, J. (2020) · Europe PMC (PubMed Central) · doi:10.30498/ijb.2020.125909.2231 · Cited by 2 · see citing works
Immunosuppressants: Remarkable Microbial Products
Vaishnav, P., Yoo, Y. J., Yoon, Y. J., & Demain, A. L. (2014) · Wiley eBooks · doi:10.1002/9783527684403.ch4 · Cited by 2 · see citing works
Xu, D., Wang, Y., Li, H., Wang, B., Chai, L., Feng, L., Ren, F., Zhao, X., & Zhang, X. (2024) · Microbial Cell Factories · doi:10.1186/s12934-024-02632-6 · Cited by 1 · see citing works
Effects of Glycerol and Shikimic Acid on Rapamycin Production in Streptomyces rapamycinicus
La, H. T. H., Nguyen, T. K. N., Dinh, H. T., Nguyen, Q. M. H., & Nguyen, M. H. (2020) · Microbiology and Biotechnology Letters · doi:10.4014/mbl.2001.01002 · Cited by 1 · see citing works
Current Update on Rapamycin Production and its Potential Clinical Implications
Patel, G. K., Patel, G. K., Goyal, R., & Waheed, S. M. (2019) · doi:10.1002/9781119460053.ch6 · Cited by 1 · see citing works
Wang, P., Yin, Y., Wang, X., & Wen, J. (2021) · Figshare · doi:10.6084/m9.figshare.14234769
- Authors
- Zhu, X., Zhang, W., Chen, X., Wu, H., Duan, Y., & Xu, Z.
- Affiliations
- Zhejiang University (CN)
- Corresponding author
- Xu, Zhinan
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2010-08-20
- Volume
- 107
- Issue
- 3
- Pages
- 506-515
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2070229485
- Cited by
- 48
- References
- 32
- Citations by year
- 2024: 1 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 9 · 2012: 1
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biotechnology and Bioengineering (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Microbial Natural Products and Biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Microbial Metabolism and Applications
- Keywords
- rapamycin, Streptomyces hygroscopicus, UV mutagenesis, glucose repression, tryptophan auxotrophy, fed-batch fermentation, fermentation optimization, industrial-scale production
- MeSH terms
- Fermentation, Glucose, Lysine, Phenylalanine, Shikimic Acid, Streptomyces, Tryptophan, Ultraviolet Rays, Mutagenesis, Sirolimus, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review